We found while screening a chemical library that indomethacin, an inhibitor of prostaglandin biosynthesis, induced strobilation (metamorphosis from the asexual to sexual stage) in the moon jellyfish, Aurelia aurita. Indomethacin initiated strobilation in a dose-dependent manner, but was not involved in the progression of strobilation. Pharmacological experiments suggested that indomethacin could induce strobilation independently of prostaglandin biosynthesis.
The moon jellyfish, Aurelia aurita, is widely distributed in the coastal waters of the world. The abundance of Aurelia aurita has recently increased in the coastal waters of Japan, including the Seto Inland Sea in southwestern Japan. The high abundance of Aurelia aurita is believed to be a possible cause of the decrease in coastal fishery resources. 1) The life cycle of Aurelia consists of 2 reproductive stages, the asexual polyp stage and the sexual medusa (jellyfish) stage. 2) Polyps in the asexual stage are propagated by fission and budding. In response to such an environmental stimulus as a decrease in sea temperature, the polyps metamorphose into strobilae which have several transverse segments in their body columns. Each segment of the strobilae eventually develops into one ephyra (juvenile jellyfish). This metamorphosis from polyp to ephyra is called ''strobilation.'' Since a single polyp can generate a number of ephyrae, strobilation is a key step in increasing the adult jellyfish population.
Strobilation can be artificially induced by lowering the temperature; 3) for example, in the case of polyps from the KH3B line, a clonal polyp strain that we established from Aurelia aurita captured in the Seto Inland Sea, strobilation was induced by lowering the culture temperature from 25 C to 10 C (Fig. 1) . No morphological alteration was apparent for a month (Fig. 1A) , and a transverse constriction was generated beneath the tentacles 4-5 weeks after the temperature drop (strobila with 1 constriction, Fig. 1B) . Generation of the first constriction is morphologically defined as the onset of strobilation. Additional constrictions are subsequently generated sequentially toward the aboral side, resulting in several segments (fully segmented strobila, Fig. 1C ). After this segmentation, the tentacles degenerated and the body column became pigmented (pigmented strobila, Fig. 1D ). Each segment metamorphosed to an ephyra ( Fig. 1E ) which was subsequently detached (Fig. 1F) . Strobilation was completed under these conditions in about 2 months ( Fig. 2A, uppermost arrow) .
The molecular mechanism for physiological strobilation remains to be elucidated. To obtain clues to clarify the molecular mechanism for strobilation, we screened a chemical library for substances to induce strobilation by using a bioassay. Briefly, 3-5 polyps reared at 25 C were incubated in individual wells of a 24-well microtiter plate in 1 mL of filtered seawater (FSW) containing 10 mg/mL of each test substance at 25 C, a temperature at which polyps would never start strobilation. The polyps were observed for 2 weeks to examine whether or not strobilation occurred.
This bioassay enabled us to identify indomethacin (2-[1-(4-chlorobenzoyl)-5-methoxy-2-methylindol-3-yl]acetic acid) as a strobilation-inducing substance among the 456 substances in the chemical library provided by the RIKEN Natural Products Depository (RIKEN NPDepo, RIKEN Advanced Science Institute, Japan).
4) The polyps became fully segmented strobilae on the 6th day in the presence of 10 mg/mL of indomethacin (Fig. 1G) , the segments then metamorphosed to ephyrae on the 8th day (Fig. 1H) , and all ephyrae finally underwent detachment in 2 weeks. Strobilation did not occur in indomethacin-free FSW (Fig. 1I) . Table 1a shows that indomethacin induced strobilation within 7 d at a concentration >2.5 mM. The timecourse characteristics of strobilation induced by 2.5-20 mM of indomethacin are shown in Fig. 2A . The higher the concentration of indomethacin, the earlier strobilation started; the first constriction was respectively observed on the 3rd, 4th, 5th, or 7th d in the presence y To whom correspondence should be addressed. Fax: +81-82-424-7916; E-mail: hkuni@hiroshima-u.ac.jp Abbreviations: COX, cyclooxygenase; ERK, extracellular signal-regulated kinase; FSW, filtered seawater; GLO1, glyoxalase 1; IM, indomethacin; NPDepo, Natural Products Depository; PG, prostaglandin; PLA2, phospholipase A2 Biosci. Biotechnol. Biochem., 76 (7), 1397-1400, 2012
Note of 20, 10, 5, or 2.5 mM of indomethacin. The duration to the onset of strobilation was therefore negatively correlated with the concentration of indomethacin (Spearman rank correlation coefficient, R s ¼ À0:906, p < 0:0001). However, the period between the onset of strobilation and the detachment of ephyrae was constant (6-7 d). We characterized the activity of indomethacin by conducting an experiment in which indomethacin was removed during the process of strobilation (Fig. 2B ). Polyps were incubated at 25 C with 50 mM of indomethacin. During the period from 2 to 6 d after administration, the polyps were rinsed 3 times with fresh FSW, placed in individual wells of a 24-well microtiter plate (3 polyps/well), and then cultured in indomethacinfree FSW. Without the removal of indomethacin, the polyps became strobilae with 1 constriction (the onset of strobilation) on the 5th d, fully segmented strobilae on the 7th d, and then ephyrae on the 9th d (Fig. 2B , bottom illustration). When indomethacin was removed 2, 3, or 4 d after administration, however, the polyps did not start strobilation. It is interesting that strobilation was not interrupted when indomethacin was removed on the 5th or 6th d after strobilation had already been initiated (Fisher's exact test, p < 0:001). It is noteworthy that, even in the absence of indomethacin, strobilation proceeded to the end (the detachment of ephyrae) at the same rate as that without removing indomethacin.
These results suggest that indomethacin induced the initiation of strobilation, but was not involved in the progression of segmentation and morphogenesis into ephyrae, and that the developmental fate to ephyrae was determined at the onset of strobilation.
Indomethacin is known to be an inhibitor of cyclooxygenase (COX), an enzyme responsible for prostaglandin (PG) biosynthesis. 5) COXs have been isolated from various species including the coral, Gersemia fruticosa.
6) Since both coral and jellyfish belong to the phylum Cnidaria, Aurelia aurita could also possess COX and PGs. If the indomethacin-induced strobilation would be due to the inhibition of Aurelia COX, it is possible that endogenous PG functions to keep the asexual polyp stage as a strobilation-suppressing factor, and that a decrease in PG results in the initiation of strobilation. However, this possibility appears unlikely considering the following three results: i) other COX inhibitors (aspirin, ibuprofen, diclofenac sodium and NS398) did not induce strobilation (Table 1b) ; ii) bromoenol lactone, an inhibitor of phospholipase A2 (PLA2) that produces arachidonic acid (the substrate of COX) in the PG biosynthesis pathway, 7) showed no strobilation-inducing activity (Table 1b) ; iii) the simultaneous administration of synthetic PGs (PGE 2 or PGF 2 ) and indomethacin did not suppress indomethacin-induced strobilation (Table 1c) . These results col- lectively suggest that the strobilation-initiating activity of indomethacin was not caused by a reduction in the PG level.
Another target of indomethacin is the extracellular signal-regulated kinase (ERK). Kobayashi et al. 8) have reported that indomethacin reduced the basal level of ERK1/2 in human cells. We examined the possibility that indomethacin-induced strobilation could have resulted from the suppression of ERK activity by testing PD98059 and U0126, both inhibitors of the ERK signaling pathway, for their strobilation-inducing activity. Both inhibitors failed to induce strobilation (Table 1d ), suggesting that the ERK pathway was unlikely to be involved in strobilation.
We found in this study that indomethacin induced strobilation in Aurelia aurita, and characterized the activity of indomethacin. Our results suggest that indomethacin could determine the developmental fate of polyps to the sexual stage; once strobilation started, it autonomously proceeded to the end with or without indomethacin. We speculate that indomethacin could artificially activate or inhibit a signaling cascade controlling physiological strobilation. Since pharmacological experiments suggested that indomethacin-induced strobilation could not have been related to either COX or ERK, indomethacin may target other unknown molecules which could constitute the signaling cascade controlling strobilation. Glyoxalase 1 (GLO1) has recently been identified as a novel target of indomethacin; 9) GLO1 is therefore a potential candidate for the strobilation-controlling protein targeted by indomethacin. The next objective will be to identify the target molecule of indomethacin in Aurelia aurita to identify the crucial step in understanding the molecular mechanism of jellyfish metamorphosis. 
